Hungary’s Richter extends licensing agreement with AbbVie

Cariprazine to be sold in more countries

Hungary Richter to issue up to HUF 70 billion worth of bonds

It would be one of the largest issuances in the central bank's programme

EMA recommends approval of new drug of Hungary's Richter

Final call on authorisation can be expected in two months

Hungary’s Richter gains EC approval for new drug

Oral contraceptive to be marketed in Europe

Hungary Richter shares dividend payment details

Key dates published

Hungary Richter CEO explains disappointing Q1 figures

Shares good news about dividend

Hungary's Richter performs below expectations in Q1

No new record in sales this quarter

Hungary Richter eyes bond issuance

Participation in central bank programme pending BoD approval

Hungary Richter sets new records - What next?

Record revenue in Q4 2020, as well

Hungary receives coronavirus drug for ambulant treatment

Bamlanivimab to arrive on Wednesday

European Commission reaches decision on Hungarian Richter's Esmya

It may be used in the EU only in certain cases

EU signs deal with Moderna for 80 million dose of 94% effective COVID-19 vaccine

With option to buy another 80 million

CHMP recommends restricting the use of Richter's Esmya

Ball now in European Commission's court

Hungary Richter stakeholder crosses north of 5% threshold

Hungary to go on with COVID drug trial

Remdesivir research continues despite WHO statement

Hungary to test favipiravir coronavirus drug

Clinical trials begin in five locations

Sanofi Hungary to upgrade syringe plant for HUF 7 bn

Increasing capacity by 50%

ANALYST VIEW - Drug of Hungary's Richter could be facing new rival

Jefferies publishes opinion

EU, AstraZeneca sign deal on COVID-19 vaccine

British drugmaker to supply 300 mn doses

Hungarian state ownership in Richter decreases

Share transfer to foundation closed